"From basic eye exams to the most advanced diagnostic tests and sophisticated surgery, the physicians and staff at Total Eye Care, P.A. provide comprehensive eye care at one convenient location in Memphis, TN. Located near St. Francis Hospital, we are one of the leading providers in cutting-edge treatment for glaucoma, cataract, dry eye, diabetic retinopathy, and other conditions that can threaten vision. Our on-site ophthalmic dispensary and custom lab provides an added convenience for our patients, with same day service available on many prescriptions. With exclusive eyewear collections and the latest contact lenses available, we strive to meet the "Total Eye Care" needs of our patients. Give us a call to request an appointment!"

During the past decade, Total Eye Care, PA conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 38 clinical trials were completed, i.e. on average, 61.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 25 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Total Eye Care, PA" #1 sponsor was "Johnson & Johnson Vision Care, Inc." with 11 trials, followed by "Allergan" with 6 trials sponsored, "Aerie Pharmaceuticals" with 3 trials sponsored, "Kala Pharmaceuticals, Inc." with 3 trials sponsored and "Santen Inc." with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Total Eye Care, PA" #1 collaborator was "ORA, Inc." with 8 trials as a collaborator, "Statistics & Data Corporation" with 2 trials as a collaborator, "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Total Eye Care, PA" are "Dry Eye" (10 trials), "Dry Eye Disease" (8 trials), "Dry Eye Syndromes" (8 trials), "Keratoconjunctivitis Sicca" (6 trials) and "Ocular Hypertension" (6 trials). Many other conditions were trialed in "Total Eye Care, PA" in a lesser frequency.

Most popular intervention types in "Total Eye Care, PA" are "Drug" (56 trials), "Device" (18 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Vehicle" (9 trials), "DE-117 Ophthalmic Solution" (3 trials), "Placebo Ophthalmic Solution" (3 trials) and "Placebos" (3 trials). Other intervention names were less common.

The vast majority of trials in "Total Eye Care, PA" are 73 trials for "All" genders.

Currently, there are NaN active trials in "Total Eye Care, PA". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Total Eye Care, PA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Total Eye Care, PA, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 15 trials that are defined as “Not Applicable".